Tag:
Oncolytics
Latest Headlines
Latest Headlines
Oncolytics raises $24M for cancer trial
Canada's Oncolytics, which is developing oncolytic viruses as potential cancer therapeutics, has raised about $24 million through the sale of 5.44 million units of the company's stock for $4.60 each.
